Spectacle Prescribing in Early Childhood (SPEC)
Description: PROJECT NARRATIVE The American Academy of Pediatric Ophthalmology and Strabismus (AAPOS) recommends screening for detection of refractive errors in toddlers 12-30 months of age, despite absence of evidence-based guidelines for prescribing spectacles to infants and toddlers. The SPEC Trial is a prospective clinical trial that will determine the developmental and visual benefits of spectacle correction of astigmatism in toddlers, and assess factors associated with spectacle treatment compliance (measured using a wearable device) in this age group. The results will provide urgently needed data on which to base spectacle prescribing recommendations for toddlers.
Funder: National Eye Institute
Funding type: cooperative_agreement
Funder scheme: UG1
Start date: 2019-06-01
End date: 2026-05-31
Investigator: JOHN DANIEL TWELKER (lead)
Institution: University of Arizona
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 5
Funder award ID: UG1EY029657
OpenAlex ID: G2906880608